SlideShare una empresa de Scribd logo
1 de 4
Descargar para leer sin conexión
ABSTRACT                                                                       SEVERE
                                                              HYPERTRIGLYCERIDEMIA
Puerto Rico blood donor issues has
been identified in cases of severe hy-                         IN PUERTO RICO BLOOD
pertriglyceridemia presenting as tur-                                        DONORS:
bid. Blood donations resulting in milky
serum must be discarded. They are                                   A Population Study
discarded because we cannot properly                                        2009-2011
test the donation. This is the first report
where we correlate turbidity and cardio-
vascular risk factors in the Puerto Rico                  Raúl H. Morales-Borges MDa*, Carmen Merced
population as well as blood types O                       MT b
and A, Rh (+) with dyslipidemia. Blood
donors should be screened in more
details regarding cardiovascular and
metabolic risks to avoid problems with                    a
                                                            Medical Director, American Red Cross, Puerto Rico Region,
recruitment and retention strategies.                     San Juan, Puerto Rico.
                                                          b
                                                            Manager, Donor Information, American Red Cross, Puerto
                                                          Rico Region, San Juan, Puerto Rico.
Index words: severe, hypertriglyceride-                   *Corresponding author: Raúl H. Morales-Borges MD - Medi-
mia, Puerto Rico, blood, donors, popu-                    cal Director, American Red Cross, Puerto Rico Region, PO
lation                                                    Box 366046 San Juan, Puerto Rico 00936. E-mail: Raul.Mo-
                                                          rales@redcross.org


INTRODUCTION

Hyperlipidemia, defined as an abnormal elevation of plas-         If a sample appears excessively turbid and fails visual exa-
ma cholesterol and/or triglyceride levels, is one of the most    mination for lipemia, the National Testing Laboratory (NTL)
common clinical problems confronting the clinician in daily      performs a quantitative triglyceride analysis. Samples with
practice (1). Although these disorders appear to be common       triglycerides value less or equal than 3000 mg/dl are con-
in the general population, it seems not a major issue in blood   sidered acceptable for testing; but samples with a triglyce-
donor’s population. A French study published by Terrier et al    ride value more than 3000 mg/dl are unsuitable for testing.
(2) with 1184 blood donors found a correlation between high      Approximately 99% of samples pass the visual examina-
blood pressure, obesity, blood group O, and type II-b Hyper-     tion for turbidity and therefore do not require a quantitative
lipoproteinemias in 32 cases. Another study from Brazil by       triglyceride analysis. Of those samples that fail the visual
MG Ferreira et al (3) evaluated the accuracy of anthropo-        examination for turbidity, greater than half have a quantitati-
metric fat location indices as predictors of dyslipidemia. One   ve value less or equal than 3000 mg/dl and are determined
study from the Netherlands provided important knowledge          acceptable for testing. Only a few samples a day fails the
about demographic distributions and cardiovascular risk          visual examination for turbidity and have a triglyceride level
factors within whole blood and plasma donors (4). Another        > 3000 mg/dl.
study also from the Netherlands reported that donors who
provided a turbid donation have a less favorable cardio-         The NTL uses the result of the triglyceride testing to deter-
vascular profile compared to other donors (5). One study         mine sample suitability and is required to report the results
about fasting blood sugar in 1188 blood donors from Mexico       to the region or to the donor. It should be noted that the
showed that the prevalence of impaired fasting glucose was       triglyceride test performed by the Charlotte NTL is to be per-
higher than expected and 70% of those subjects showed            formed on non-fasting sample, which is usually the case for
hypertriglyceridemia, comparing with other populations re-       our donor samples. The expected value for a fasting sample
ported in the literature (6). We wanted to demonstrate the       is < 200 mg/dl. The package insert does not include any
needs of further research on the role of blood donation in       expected values for non-fasting samples. Because there is
cardiovascular risk reduction, correlation between blood         no expected value for a non-fasting sample, the testing is
type and groups with dyslipidemia. We are presenting data        performed to determine sample suitability for infectious di-
from 50248 whole blood donors from March 1 to October 31         sease testing (8)
of 2011 from which 5 were identified to have a triglyceride
level above 3000 mg/dl. There is additional data from April of   Once the donors are identified we pulled the blood donors
2009 to December of 2010 with a total of 9 donors identified     registry, known as BDR, of them and we reviewed to chart
with high triglyceride levels identified when the BHQ Medi-      the data of age, gender, weight, blood type and group, town
cal Office asked the National’s Testing Laboratory (NTL) to      or city of living, collection date, and serum triglyceride level.
systemically notify the regional physicians of donations that
could not be tested because of high triglyceride levels.         Puerto Rico has 78 municipalities and we colored the muni-
                                                                 cipalities or cities of the affected donors.
METHODS
                                                                 RESULTS
We obtained the cases were a visual examination of all
blood tubes is performed as part of the National’s Testing       Five blood donors were identified to have turbid plasma with
Laboratory sample suitability evaluation. Lipemia is one of      triglycerides over 3000 mg/dl. Four were male and the avera-
the variables assessed during this initial visual examination    ge/median age was 46 years with a range of 41 to 50 years old.
as shown also in a study from K Peffer et al and commented       The average weight was 184 pounds with a range of 140 to 240
by RR Vassallo and FM Stearns with 272 donors (5, 7).            pounds. Four of the blood donors were identified overweight.

                                                              15
Four were identified the blood type and group with three of      One study determined 32% as the overall prevalence of the
them as A, Rh (+). Three of them are from the north area of      metabolic syndrome (defined as diabetes, hypertension,
the Island and one from the south and central area respec-       obesity, dyslipidemia, glucose intolerance, and hyperinsu-
tively. The lowest triglyceride level was 3038 mg/dl and the     linemia) among a determined Puerto Rican population (9).
highest was 5701 mg/dl with an average level of 3912 mg/         Cox stated that despite clear and consistent clinical-trial
dl (See Table 1).                                                evidence establishing a causal link between lipid disorders
                                                                                                   and coronary heart di-
                                                                                                   sease and that choles-
                                                                                                   terol-lowering     therapy
                                                                                                   dramatically reduces the
                                                                                                   risk for that disease and
                                                                                                   its complications, many
                                                                                                   patients for whom such
                                                                                                   treatment is indicated re-
                                                                                                   main either unidentified
                                                                                                   or untreated (10).

                                                                                                     With that in mind we
                                                                                                     found that dyslipidemia
                                                                                                     might be a problem in
                                                                                                     this population, but our
                                                                                                     data is on isolated non-
                                                                                                     fasting triglyceride levels.
                                                                                                     This might be taken in
                                                                                                     consideration when we
                                                                                                     are doing blood drives
                                                                                                     and we need to educate
                                                                                                     more our people about
From 2009 to 2010 we identified nine male donors with an         good health habits and cardiovascular risks. Also discarding
average age of 44 years and a range of 30 to 56 years old.       donations may have a negative impact on donor satisfaction
Five of them have blood type and group O, Rh (+). The geo-       and retention, although the educational material informs all
graphic distribution varies with four from the Central region,   donors that their donation may not be tested, but ARC does
three from the North, and two from the Metropolitan region.      not inform donors if their donations are discarded.
The lowest triglyceride level was 2153 mg/dl, the highest
was 5396 mg/dl with an average 3545 mg/dl (See Table 2).         Regarding turbid plasma donations, Peffer et al (5) mentio-
                                                                 ned that in the Netherlands, 3 to 4 per 1000 whole blood
In general we are reporting 14 cases with an average age         donations reveal turbid plasma. Familial hypertriglyceride-
of 44.5 years and the majority were males from the North         mia or chylomicronemia has been reported, but commonly
Central Municipalities of the Island (See Figure 1).             occurs among donors who ate a fatty meal before donation
                                                                                      as well in obese diabetic donors with
                                                                                      unfavorable cardiovascular profile.
                                                                                      They found no difference between
                                                                                      plasma or whole blood donors. The
                                                                                      mean age of participating cases was
                                                                                      46.1 years as well as in our small num-
                                                                                      ber of blood donors on 2011, although
                                                                                      the average age of the 14 cases was
                                                                                      44.5 years. Men were more frequent
                                                                                      in their study along with ours. One im-
                                                                                      portant data from their study was the
                                                                                      question of when was their last meal
                                                                                      before donation and we missed this
                                                                                      information. Without this information
                                                                                      and without any follow-up on the do-
                                                                                      nors, it is impossible to interpret the
                                                                                      relevance of an isolated high triglyce-
                                                                                      ride level.

                                                                                        The main blood type and group of our
                                                                                        groups was O, Rh (+) followed by A,
                                                                                        Rh (+). This is the first report from our
                                                                                        knowledge regarding a Puerto Rico
                                                                                        population. There is one paper by J
                                                                                        Hørby et al from Denmark (11) where
                                                                                        they showed a small group study of
                                                                                        a relation of serum lipids to the ABO
                                                                                        blood groups in 66 patients with inter-
                                                                                        mittent claudication. The concluded
                                                                                        that the serum lipoprotein and lipid le-
                                                                                        vels do not give an obvious explana-
                                                                                        tion why patients with blood group A
DISCUSSION                                                       seem more liable to develop atherosclerosis than those with
                                                                 blood group non-A. This data correlates with an Italian study
This is the first publication were we identified turbid plasma   from Clara Carpeggiani et al (12) where they demonstrated
in Puerto Rico blood donors with a correlation of gender,        that a significant association between group non-O and fa-
age, regional area where they live, and blood type/group.        mily history of ischemic heart disease, hypercholesterolemia

                                                             16
had a rate 10-times higher.

                                                                     Blood donors should be screened
                                                                     in more details regarding cardio-
                                                                     vascular and metabolic risks to
                                                                     avoid problems with recruitment
                                                                     and retention strategies. A future
                                                                     and larger study is recommended.

                                                                     REFERENCES

                                                                     1. Witztum JL, Steinberg D: The
                                                                     Hyperlipoproteinemias      (Chapter
                                                                     206). In Goldman L,
                                                                         Bennett JC, eds. Cecil Textbook
                                                                     of Medicine. Philadelphia: W.B.
                                                                     Saunders Company,
                                                                        2000: 1090-1100.
                                                                     2. Terrier E, Baillet M, Jaulmes B:
                                                                     Detection of lipid abnormalities in
                                                                     blood donors.
                                                                         Rev Fr Transfus Immunohema-
                                                                     tol. 1979 Mar; 22(2): 147-158.
                                                                     3. Ferreira MG, Valente JG, Gon-
                                                                     calves-Silva RM, Sichieri R: Accu
and presence of coronary atheros-          racy of waist
clerosis. Their higher predictor group         circumference and waist-to-hip ratio as predictors of dys-
were patients aged < 65 years old and      lipidemia in a cross-sectional
women. JL Cronenwett et al (13) with          study among blood donors in Cuiaba, Mato Grosso State,
73 women requiring aortoiliac recons-      Brazil. Cad Saude Publica
truction for atherosclerotic occlusive         2006 Feb; 22(2): 307-314.
disease demonstrated that women            4. Atsma F, Veldhuizen I, de Vegt F, Doggen C, de Kort W:
with blood group A had increased fre-      Cardiovascular and
quency as comparable to published              demographic characteristics in whole blood and plasma
data. The only study that does not co-     donors: results from the Donor InSight study. Transfusion
rrelate with this data is the one from     2011 Feb; 51(2): 412-420.
North Carolina, USA with 1198 pa-          5. Peffer K, de Kort WL, Slot E, Doggen CJ: Turbid plasma
tients who underwent percutaneous          donations in whole blood
coronary intervention and patients             donors: fat chance? Transfusion 2011 Jun; 51(6): 1179-
with O blood type were slightly older      1187.
(62 years old), had a higher prevalen-     6. Munguia-Miranda C, Sánchez-Barrera RG, Tuz K, Alon-
ce of hypercholesterolemia and had         so-García AL, Cruz M:
a higher burden of atherosclerosis            Impaired casting glucose detection in blood donor’s popu-
with more vascular disease (14). This      lation. Rev Med Inst Mex
fact is important regarding blood do-          Seguro Soc. 2009 Jan-Feb; 47(1): 17-24.
nations. A study must be performing        7. Vassallo RR, Stearns FM: Lipemic plasma: a renaissan-
to correlate the blood type/group and      ce. Transfusion 2011 Feb;
dyslipidemia because it may be a               51(6): 1136-1139.
coincidental finding.                      8. Stearns FM, Stramer SL, Alvarez AW: Verification of Vi-
                                           sual Lipemia Sample
Another piece of information regarding          Suitability by Quantitative Triglyceride Testing. Transfu-
strategies for blood drives is that the    sion 2005; 45, Supplement,
majority of the small groups were from         SP199, p89A.
the north and central areas of Puerto
Rico. This is important, although, the     9. Gomez M, Ramirez M, Disdier O: Prevalence of the meta-
finding of a few donors with isolated      bolic syndrome among a
high triglyceride levels does not have         determined Puerto Rican population. PR Health Sci J.
any implications for planning blood        2006 Jun; 25(2): 111-116.
drives.                                    10. Cox RA: The hyperlipidemias. Bol Asoc Med PR. 2003
                                           Sep-Oct; 95(5): 36-44.
CONCLUSIONS                                11. Hørby J, Gyrtrup HJ, Grande P, Vestergaard A: Relation
                                           of serum lipoproteins and
This     data    provided    important          lipids to the ABO blood groups in patients with intermit-
knowledge about lipemic plasma and         tent claudication.
demographics of our blood donor’s               J Cardiovasc Surg (Torino) 1989 Jul-Aug; 30(4):533-
population. It was confirmed that the      537.
main blood type and group O, Rh (+)        12. Carpeggiani C, Coceani M, Landi P, Michelassi C,
is related with dyslipidemia as well as    L’abbate A: ABO blood group
A, Rh (+) by our small sample and               alleles: A risk factor for coronary artery disease. An an-
they are mostly located in the north       giographic study.
central municipalities of Puerto Rico.         Atherosclerosis 2010 Aug; 211(2): 461-466.
What is most interesting is Figure 1       13. Cronenwett JL, Davis JT Jr, Garret HE: ABO blood group
per 130,000 of severe hypertriglyce-       and serum lipids in female
ridemia in which Ralph R. Vassallo               atherosclerosis. J Cardiovasc Surg (Torino) 1983 Nov-
and Frank M. Stearns (7) reported for      Dec; 24(6): 658-661.
the Philadelphia NTL were our donors       14. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate

                                          17
RJ, Kutcher MA, Sane                                             RESUMEN
   DC: ABO blood types: Influence on infarct size, procedural
characteristics and                                              Se ha identificado un asunto en cuanto a donantes de sangre
    prognosis. Thromb Res 2008; 123(2): 200-205.                 puertorriqueños con hipertrigliceridemia presentándose como
                                                                 plasma turbio en hombres con sobre peso y una edad prome-
                                                                 dio 44.5 años. Las donaciones de sangre resultantes en suero
ACKNOWLEDEDGMENTS                                                lechoso usualmente son descartadas. Se descartan porque
                                                                 no se pueden realizar las pruebas a las donaciones. Este es
The authors thank Dr. Anne F. Eder, Dr. Ralph R. Vassallo, and   el primer reporte donde nosotros correlacionamos la turbiedad
Dr. Frank M. Stearns from the American Red Cross for their       y los factores de riesgo cardiovasculares en la población de
editing support and comments.                                    Puerto Rico asi como los tipos y grupos sanguíneos O y A,
                                                                 Rh (+) con dislipidemia. Los donantes de sangre deben recibir
                                                                 un cernimiento mas detallado sobre los riesgos de padecer
                                                                 enfermedad cardiovascular o síndrome metabólico para evitar
                                                                 problemas con su reclutamiento.



  Every week,

  ... in your email address...



                 Visit our website:
               www.asocmedpr.org
       and click on “Sign up Today”
                          button,
     fill the form, and receive in your
                e-mail, each week,
                news and informa-
   tion about conferences, continued
            medical education, and
             all you need to be well
             informed about health.




                                   Information: www.asocmedpr.org



                                                            18

Más contenido relacionado

La actualidad más candente

THE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CAD
THE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CADTHE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CAD
THE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CADSunil Wadhwa
 
Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceTreatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceVishwanath Hesarur
 
Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient FELIX NUNURA
 
00003246 201506000-00015
00003246 201506000-0001500003246 201506000-00015
00003246 201506000-00015thawasit
 
DM2_AKR1B1 Tachmitzi et al 2015
DM2_AKR1B1 Tachmitzi et al 2015DM2_AKR1B1 Tachmitzi et al 2015
DM2_AKR1B1 Tachmitzi et al 2015Koutsiaris Aris
 
Crestor Presentation
Crestor PresentationCrestor Presentation
Crestor Presentationhospital
 
Indications of liver transplantation and scoring syatems.
Indications of liver transplantation and scoring syatems.Indications of liver transplantation and scoring syatems.
Indications of liver transplantation and scoring syatems.Mayur Rath
 
Statin drugs are they worth the risks
Statin drugs are they worth the risksStatin drugs are they worth the risks
Statin drugs are they worth the risksDIPAK PATADE
 
Atorvastatin
AtorvastatinAtorvastatin
Atorvastatinkenny_gwc
 
Hepatorenal Syndrome
Hepatorenal Syndrome Hepatorenal Syndrome
Hepatorenal Syndrome Pratap Tiwari
 
Guidelines For Assessment Of C Visk In Rsymptomatic Adults
Guidelines For Assessment Of C Visk In Rsymptomatic AdultsGuidelines For Assessment Of C Visk In Rsymptomatic Adults
Guidelines For Assessment Of C Visk In Rsymptomatic AdultsJuan Menendez
 
10.1007@s10067 018-04416-x
10.1007@s10067 018-04416-x10.1007@s10067 018-04416-x
10.1007@s10067 018-04416-xAndi Wahyudi
 
Statin-induced Myalgia and Myositis
Statin-induced Myalgia and Myositis Statin-induced Myalgia and Myositis
Statin-induced Myalgia and Myositis Ade Wijaya
 
Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...
Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...
Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...science journals
 

La actualidad más candente (20)

THE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CAD
THE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CADTHE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CAD
THE ROLLER COASTER RIDE OF DYSLIPIDEMIA & CAD
 
11. DM STUDY
11. DM STUDY11. DM STUDY
11. DM STUDY
 
Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceTreatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intolerance
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient
 
00003246 201506000-00015
00003246 201506000-0001500003246 201506000-00015
00003246 201506000-00015
 
DM2_AKR1B1 Tachmitzi et al 2015
DM2_AKR1B1 Tachmitzi et al 2015DM2_AKR1B1 Tachmitzi et al 2015
DM2_AKR1B1 Tachmitzi et al 2015
 
Crestor Presentation
Crestor PresentationCrestor Presentation
Crestor Presentation
 
Indications of liver transplantation and scoring syatems.
Indications of liver transplantation and scoring syatems.Indications of liver transplantation and scoring syatems.
Indications of liver transplantation and scoring syatems.
 
Cvd risk in dm
Cvd risk in dmCvd risk in dm
Cvd risk in dm
 
Ojchd.000542
Ojchd.000542Ojchd.000542
Ojchd.000542
 
Meld scoring
Meld scoringMeld scoring
Meld scoring
 
Statin drugs are they worth the risks
Statin drugs are they worth the risksStatin drugs are they worth the risks
Statin drugs are they worth the risks
 
Statin Use and Diabetes Risk
Statin Use and Diabetes RiskStatin Use and Diabetes Risk
Statin Use and Diabetes Risk
 
Atorvastatin
AtorvastatinAtorvastatin
Atorvastatin
 
Hepatorenal Syndrome
Hepatorenal Syndrome Hepatorenal Syndrome
Hepatorenal Syndrome
 
Guidelines For Assessment Of C Visk In Rsymptomatic Adults
Guidelines For Assessment Of C Visk In Rsymptomatic AdultsGuidelines For Assessment Of C Visk In Rsymptomatic Adults
Guidelines For Assessment Of C Visk In Rsymptomatic Adults
 
10.1007@s10067 018-04416-x
10.1007@s10067 018-04416-x10.1007@s10067 018-04416-x
10.1007@s10067 018-04416-x
 
Statin-induced Myalgia and Myositis
Statin-induced Myalgia and Myositis Statin-induced Myalgia and Myositis
Statin-induced Myalgia and Myositis
 
Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...
Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...
Polymorphisms rs1800587 and rs1143634 of the Interleukin-1α Gene are associat...
 

Destacado

Modelio open source UML BPMN
Modelio open source UML BPMNModelio open source UML BPMN
Modelio open source UML BPMNAndrey Sadovykh
 
Verses of success in meditation
Verses of success in meditationVerses of success in meditation
Verses of success in meditationAmphan Sutalangka
 
Hepatocellular &amp; Pancreatic Carcinomas
Hepatocellular &amp; Pancreatic CarcinomasHepatocellular &amp; Pancreatic Carcinomas
Hepatocellular &amp; Pancreatic CarcinomasRHMBONCO
 
Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12
Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12
Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12RHMBONCO
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRHMBONCO
 
Clinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisClinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisRHMBONCO
 
les aperos du jeudi : retour d'experience
les aperos du jeudi : retour d'experienceles aperos du jeudi : retour d'experience
les aperos du jeudi : retour d'experiencenous sommes vivants
 

Destacado (9)

Modelio open source UML BPMN
Modelio open source UML BPMNModelio open source UML BPMN
Modelio open source UML BPMN
 
Verses of success in meditation
Verses of success in meditationVerses of success in meditation
Verses of success in meditation
 
Hepatocellular &amp; Pancreatic Carcinomas
Hepatocellular &amp; Pancreatic CarcinomasHepatocellular &amp; Pancreatic Carcinomas
Hepatocellular &amp; Pancreatic Carcinomas
 
Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12
Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12
Sangamos Hiv Study Slides Dr 1. Morales Borges Of Arc 09.12.12
 
Softeam profile 2014
Softeam profile 2014Softeam profile 2014
Softeam profile 2014
 
Trali
TraliTrali
Trali
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And Management
 
Clinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic ApheresisClinical Applications Of Therapeutic Apheresis
Clinical Applications Of Therapeutic Apheresis
 
les aperos du jeudi : retour d'experience
les aperos du jeudi : retour d'experienceles aperos du jeudi : retour d'experience
les aperos du jeudi : retour d'experience
 

Similar a Articulo Hypertrigyceridemia In Blood Donors En Boletin Asoc Med Pr

CVD Egypt Clinical Diabetes Reprint Summer 2010
CVD Egypt Clinical Diabetes Reprint Summer 2010CVD Egypt Clinical Diabetes Reprint Summer 2010
CVD Egypt Clinical Diabetes Reprint Summer 2010Mahmoud IBRAHIM
 
Diabet med 2009_sep_26(9)_864-71[1]
Diabet med 2009_sep_26(9)_864-71[1]Diabet med 2009_sep_26(9)_864-71[1]
Diabet med 2009_sep_26(9)_864-71[1]Manuel F. Miyamoto
 
Prevalence of blood pressure, glucose and lipid abnomalities among eth
Prevalence of blood pressure, glucose and lipid abnomalities among ethPrevalence of blood pressure, glucose and lipid abnomalities among eth
Prevalence of blood pressure, glucose and lipid abnomalities among ethYisehak Tura
 
A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...
A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...
A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...IOSRJPBS
 
Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...AdvancingDialysis.org
 
Goal attainments and their discrepancies for low density lipoprotein choleste...
Goal attainments and their discrepancies for low density lipoprotein choleste...Goal attainments and their discrepancies for low density lipoprotein choleste...
Goal attainments and their discrepancies for low density lipoprotein choleste...Paul Schoenhagen
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Erwin Chiquete, MD, PhD
 
Dm &amp; liver
Dm &amp;  liverDm &amp;  liver
Dm &amp; liveralaa wafa
 
Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]Manuel F. Miyamoto
 
Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]Manuel F. Miyamoto
 
ANGINA: Treatment by Alternative Therapeutic Principal?
ANGINA: Treatment by Alternative Therapeutic Principal?ANGINA: Treatment by Alternative Therapeutic Principal?
ANGINA: Treatment by Alternative Therapeutic Principal?Dr Tarique Ahmed Maka
 
Chronic Kidney Disease Silent Epidemic
Chronic Kidney Disease   Silent EpidemicChronic Kidney Disease   Silent Epidemic
Chronic Kidney Disease Silent EpidemicAndre Garcia
 
Nejm199807233390404
Nejm199807233390404Nejm199807233390404
Nejm199807233390404lolilopez93
 
Safe and successful restriction of transfusion
Safe and successful restriction of transfusionSafe and successful restriction of transfusion
Safe and successful restriction of transfusionanestesiahsb
 

Similar a Articulo Hypertrigyceridemia In Blood Donors En Boletin Asoc Med Pr (20)

CVD Egypt Clinical Diabetes Reprint Summer 2010
CVD Egypt Clinical Diabetes Reprint Summer 2010CVD Egypt Clinical Diabetes Reprint Summer 2010
CVD Egypt Clinical Diabetes Reprint Summer 2010
 
Vasudha main
Vasudha mainVasudha main
Vasudha main
 
Diabet med 2009_sep_26(9)_864-71[1]
Diabet med 2009_sep_26(9)_864-71[1]Diabet med 2009_sep_26(9)_864-71[1]
Diabet med 2009_sep_26(9)_864-71[1]
 
Prevalence of blood pressure, glucose and lipid abnomalities among eth
Prevalence of blood pressure, glucose and lipid abnomalities among ethPrevalence of blood pressure, glucose and lipid abnomalities among eth
Prevalence of blood pressure, glucose and lipid abnomalities among eth
 
A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...
A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...
A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus G...
 
Correlation study between total lipid profile and glycosylated hemoglobin amo...
Correlation study between total lipid profile and glycosylated hemoglobin amo...Correlation study between total lipid profile and glycosylated hemoglobin amo...
Correlation study between total lipid profile and glycosylated hemoglobin amo...
 
Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...
 
Goal attainments and their discrepancies for low density lipoprotein choleste...
Goal attainments and their discrepancies for low density lipoprotein choleste...Goal attainments and their discrepancies for low density lipoprotein choleste...
Goal attainments and their discrepancies for low density lipoprotein choleste...
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
 
Dm &amp; liver
Dm &amp;  liverDm &amp;  liver
Dm &amp; liver
 
C044008010
C044008010C044008010
C044008010
 
Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]
 
Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]Cardiovasc diabetol 2009_sep_26_8_52[1]
Cardiovasc diabetol 2009_sep_26_8_52[1]
 
Hope 3 FUTURE HOPES
Hope 3  FUTURE HOPESHope 3  FUTURE HOPES
Hope 3 FUTURE HOPES
 
ANGINA: Treatment by Alternative Therapeutic Principal?
ANGINA: Treatment by Alternative Therapeutic Principal?ANGINA: Treatment by Alternative Therapeutic Principal?
ANGINA: Treatment by Alternative Therapeutic Principal?
 
Chronic Kidney Disease Silent Epidemic
Chronic Kidney Disease   Silent EpidemicChronic Kidney Disease   Silent Epidemic
Chronic Kidney Disease Silent Epidemic
 
Non-alcoholic Fatty Liver Disease (NAFLD) and its association with metabolic ...
Non-alcoholic Fatty Liver Disease (NAFLD) and its association with metabolic ...Non-alcoholic Fatty Liver Disease (NAFLD) and its association with metabolic ...
Non-alcoholic Fatty Liver Disease (NAFLD) and its association with metabolic ...
 
Nejm199807233390404
Nejm199807233390404Nejm199807233390404
Nejm199807233390404
 
Safe and successful restriction of transfusion
Safe and successful restriction of transfusionSafe and successful restriction of transfusion
Safe and successful restriction of transfusion
 
Jnc8 2014
Jnc8 2014Jnc8 2014
Jnc8 2014
 

Más de RHMBONCO

Autosomal Dominant Inheritance of PGM in a family from PR
Autosomal Dominant Inheritance of PGM in a family from PRAutosomal Dominant Inheritance of PGM in a family from PR
Autosomal Dominant Inheritance of PGM in a family from PRRHMBONCO
 
Biosketch 2012 R Morales Borges
Biosketch 2012 R Morales BorgesBiosketch 2012 R Morales Borges
Biosketch 2012 R Morales BorgesRHMBONCO
 
Presentation Of Dengue Arc Washington Sept 2011[1]
Presentation Of Dengue  Arc Washington Sept 2011[1]Presentation Of Dengue  Arc Washington Sept 2011[1]
Presentation Of Dengue Arc Washington Sept 2011[1]RHMBONCO
 
Diseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And OthersDiseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And OthersRHMBONCO
 
UtilizacióN De Componentes De Sangre
UtilizacióN De Componentes De SangreUtilizacióN De Componentes De Sangre
UtilizacióN De Componentes De SangreRHMBONCO
 
Transfusion Reactions Evaluation &amp; Management
Transfusion Reactions Evaluation &amp; ManagementTransfusion Reactions Evaluation &amp; Management
Transfusion Reactions Evaluation &amp; ManagementRHMBONCO
 
A Practical Approach To Apheresis In Sickle Cell
A Practical Approach To Apheresis In Sickle CellA Practical Approach To Apheresis In Sickle Cell
A Practical Approach To Apheresis In Sickle CellRHMBONCO
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerRHMBONCO
 
Conferencia De Cáncer De Seno Al PúBlico
Conferencia De Cáncer De Seno Al PúBlicoConferencia De Cáncer De Seno Al PúBlico
Conferencia De Cáncer De Seno Al PúBlicoRHMBONCO
 

Más de RHMBONCO (9)

Autosomal Dominant Inheritance of PGM in a family from PR
Autosomal Dominant Inheritance of PGM in a family from PRAutosomal Dominant Inheritance of PGM in a family from PR
Autosomal Dominant Inheritance of PGM in a family from PR
 
Biosketch 2012 R Morales Borges
Biosketch 2012 R Morales BorgesBiosketch 2012 R Morales Borges
Biosketch 2012 R Morales Borges
 
Presentation Of Dengue Arc Washington Sept 2011[1]
Presentation Of Dengue  Arc Washington Sept 2011[1]Presentation Of Dengue  Arc Washington Sept 2011[1]
Presentation Of Dengue Arc Washington Sept 2011[1]
 
Diseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And OthersDiseminated Intravascular Coagulopathy And Others
Diseminated Intravascular Coagulopathy And Others
 
UtilizacióN De Componentes De Sangre
UtilizacióN De Componentes De SangreUtilizacióN De Componentes De Sangre
UtilizacióN De Componentes De Sangre
 
Transfusion Reactions Evaluation &amp; Management
Transfusion Reactions Evaluation &amp; ManagementTransfusion Reactions Evaluation &amp; Management
Transfusion Reactions Evaluation &amp; Management
 
A Practical Approach To Apheresis In Sickle Cell
A Practical Approach To Apheresis In Sickle CellA Practical Approach To Apheresis In Sickle Cell
A Practical Approach To Apheresis In Sickle Cell
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of Cancer
 
Conferencia De Cáncer De Seno Al PúBlico
Conferencia De Cáncer De Seno Al PúBlicoConferencia De Cáncer De Seno Al PúBlico
Conferencia De Cáncer De Seno Al PúBlico
 

Articulo Hypertrigyceridemia In Blood Donors En Boletin Asoc Med Pr

  • 1. ABSTRACT SEVERE HYPERTRIGLYCERIDEMIA Puerto Rico blood donor issues has been identified in cases of severe hy- IN PUERTO RICO BLOOD pertriglyceridemia presenting as tur- DONORS: bid. Blood donations resulting in milky serum must be discarded. They are A Population Study discarded because we cannot properly 2009-2011 test the donation. This is the first report where we correlate turbidity and cardio- vascular risk factors in the Puerto Rico Raúl H. Morales-Borges MDa*, Carmen Merced population as well as blood types O MT b and A, Rh (+) with dyslipidemia. Blood donors should be screened in more details regarding cardiovascular and metabolic risks to avoid problems with a Medical Director, American Red Cross, Puerto Rico Region, recruitment and retention strategies. San Juan, Puerto Rico. b Manager, Donor Information, American Red Cross, Puerto Rico Region, San Juan, Puerto Rico. Index words: severe, hypertriglyceride- *Corresponding author: Raúl H. Morales-Borges MD - Medi- mia, Puerto Rico, blood, donors, popu- cal Director, American Red Cross, Puerto Rico Region, PO lation Box 366046 San Juan, Puerto Rico 00936. E-mail: Raul.Mo- rales@redcross.org INTRODUCTION Hyperlipidemia, defined as an abnormal elevation of plas- If a sample appears excessively turbid and fails visual exa- ma cholesterol and/or triglyceride levels, is one of the most mination for lipemia, the National Testing Laboratory (NTL) common clinical problems confronting the clinician in daily performs a quantitative triglyceride analysis. Samples with practice (1). Although these disorders appear to be common triglycerides value less or equal than 3000 mg/dl are con- in the general population, it seems not a major issue in blood sidered acceptable for testing; but samples with a triglyce- donor’s population. A French study published by Terrier et al ride value more than 3000 mg/dl are unsuitable for testing. (2) with 1184 blood donors found a correlation between high Approximately 99% of samples pass the visual examina- blood pressure, obesity, blood group O, and type II-b Hyper- tion for turbidity and therefore do not require a quantitative lipoproteinemias in 32 cases. Another study from Brazil by triglyceride analysis. Of those samples that fail the visual MG Ferreira et al (3) evaluated the accuracy of anthropo- examination for turbidity, greater than half have a quantitati- metric fat location indices as predictors of dyslipidemia. One ve value less or equal than 3000 mg/dl and are determined study from the Netherlands provided important knowledge acceptable for testing. Only a few samples a day fails the about demographic distributions and cardiovascular risk visual examination for turbidity and have a triglyceride level factors within whole blood and plasma donors (4). Another > 3000 mg/dl. study also from the Netherlands reported that donors who provided a turbid donation have a less favorable cardio- The NTL uses the result of the triglyceride testing to deter- vascular profile compared to other donors (5). One study mine sample suitability and is required to report the results about fasting blood sugar in 1188 blood donors from Mexico to the region or to the donor. It should be noted that the showed that the prevalence of impaired fasting glucose was triglyceride test performed by the Charlotte NTL is to be per- higher than expected and 70% of those subjects showed formed on non-fasting sample, which is usually the case for hypertriglyceridemia, comparing with other populations re- our donor samples. The expected value for a fasting sample ported in the literature (6). We wanted to demonstrate the is < 200 mg/dl. The package insert does not include any needs of further research on the role of blood donation in expected values for non-fasting samples. Because there is cardiovascular risk reduction, correlation between blood no expected value for a non-fasting sample, the testing is type and groups with dyslipidemia. We are presenting data performed to determine sample suitability for infectious di- from 50248 whole blood donors from March 1 to October 31 sease testing (8) of 2011 from which 5 were identified to have a triglyceride level above 3000 mg/dl. There is additional data from April of Once the donors are identified we pulled the blood donors 2009 to December of 2010 with a total of 9 donors identified registry, known as BDR, of them and we reviewed to chart with high triglyceride levels identified when the BHQ Medi- the data of age, gender, weight, blood type and group, town cal Office asked the National’s Testing Laboratory (NTL) to or city of living, collection date, and serum triglyceride level. systemically notify the regional physicians of donations that could not be tested because of high triglyceride levels. Puerto Rico has 78 municipalities and we colored the muni- cipalities or cities of the affected donors. METHODS RESULTS We obtained the cases were a visual examination of all blood tubes is performed as part of the National’s Testing Five blood donors were identified to have turbid plasma with Laboratory sample suitability evaluation. Lipemia is one of triglycerides over 3000 mg/dl. Four were male and the avera- the variables assessed during this initial visual examination ge/median age was 46 years with a range of 41 to 50 years old. as shown also in a study from K Peffer et al and commented The average weight was 184 pounds with a range of 140 to 240 by RR Vassallo and FM Stearns with 272 donors (5, 7). pounds. Four of the blood donors were identified overweight. 15
  • 2. Four were identified the blood type and group with three of One study determined 32% as the overall prevalence of the them as A, Rh (+). Three of them are from the north area of metabolic syndrome (defined as diabetes, hypertension, the Island and one from the south and central area respec- obesity, dyslipidemia, glucose intolerance, and hyperinsu- tively. The lowest triglyceride level was 3038 mg/dl and the linemia) among a determined Puerto Rican population (9). highest was 5701 mg/dl with an average level of 3912 mg/ Cox stated that despite clear and consistent clinical-trial dl (See Table 1). evidence establishing a causal link between lipid disorders and coronary heart di- sease and that choles- terol-lowering therapy dramatically reduces the risk for that disease and its complications, many patients for whom such treatment is indicated re- main either unidentified or untreated (10). With that in mind we found that dyslipidemia might be a problem in this population, but our data is on isolated non- fasting triglyceride levels. This might be taken in consideration when we are doing blood drives and we need to educate more our people about From 2009 to 2010 we identified nine male donors with an good health habits and cardiovascular risks. Also discarding average age of 44 years and a range of 30 to 56 years old. donations may have a negative impact on donor satisfaction Five of them have blood type and group O, Rh (+). The geo- and retention, although the educational material informs all graphic distribution varies with four from the Central region, donors that their donation may not be tested, but ARC does three from the North, and two from the Metropolitan region. not inform donors if their donations are discarded. The lowest triglyceride level was 2153 mg/dl, the highest was 5396 mg/dl with an average 3545 mg/dl (See Table 2). Regarding turbid plasma donations, Peffer et al (5) mentio- ned that in the Netherlands, 3 to 4 per 1000 whole blood In general we are reporting 14 cases with an average age donations reveal turbid plasma. Familial hypertriglyceride- of 44.5 years and the majority were males from the North mia or chylomicronemia has been reported, but commonly Central Municipalities of the Island (See Figure 1). occurs among donors who ate a fatty meal before donation as well in obese diabetic donors with unfavorable cardiovascular profile. They found no difference between plasma or whole blood donors. The mean age of participating cases was 46.1 years as well as in our small num- ber of blood donors on 2011, although the average age of the 14 cases was 44.5 years. Men were more frequent in their study along with ours. One im- portant data from their study was the question of when was their last meal before donation and we missed this information. Without this information and without any follow-up on the do- nors, it is impossible to interpret the relevance of an isolated high triglyce- ride level. The main blood type and group of our groups was O, Rh (+) followed by A, Rh (+). This is the first report from our knowledge regarding a Puerto Rico population. There is one paper by J Hørby et al from Denmark (11) where they showed a small group study of a relation of serum lipids to the ABO blood groups in 66 patients with inter- mittent claudication. The concluded that the serum lipoprotein and lipid le- vels do not give an obvious explana- tion why patients with blood group A DISCUSSION seem more liable to develop atherosclerosis than those with blood group non-A. This data correlates with an Italian study This is the first publication were we identified turbid plasma from Clara Carpeggiani et al (12) where they demonstrated in Puerto Rico blood donors with a correlation of gender, that a significant association between group non-O and fa- age, regional area where they live, and blood type/group. mily history of ischemic heart disease, hypercholesterolemia 16
  • 3. had a rate 10-times higher. Blood donors should be screened in more details regarding cardio- vascular and metabolic risks to avoid problems with recruitment and retention strategies. A future and larger study is recommended. REFERENCES 1. Witztum JL, Steinberg D: The Hyperlipoproteinemias (Chapter 206). In Goldman L, Bennett JC, eds. Cecil Textbook of Medicine. Philadelphia: W.B. Saunders Company, 2000: 1090-1100. 2. Terrier E, Baillet M, Jaulmes B: Detection of lipid abnormalities in blood donors. Rev Fr Transfus Immunohema- tol. 1979 Mar; 22(2): 147-158. 3. Ferreira MG, Valente JG, Gon- calves-Silva RM, Sichieri R: Accu and presence of coronary atheros- racy of waist clerosis. Their higher predictor group circumference and waist-to-hip ratio as predictors of dys- were patients aged < 65 years old and lipidemia in a cross-sectional women. JL Cronenwett et al (13) with study among blood donors in Cuiaba, Mato Grosso State, 73 women requiring aortoiliac recons- Brazil. Cad Saude Publica truction for atherosclerotic occlusive 2006 Feb; 22(2): 307-314. disease demonstrated that women 4. Atsma F, Veldhuizen I, de Vegt F, Doggen C, de Kort W: with blood group A had increased fre- Cardiovascular and quency as comparable to published demographic characteristics in whole blood and plasma data. The only study that does not co- donors: results from the Donor InSight study. Transfusion rrelate with this data is the one from 2011 Feb; 51(2): 412-420. North Carolina, USA with 1198 pa- 5. Peffer K, de Kort WL, Slot E, Doggen CJ: Turbid plasma tients who underwent percutaneous donations in whole blood coronary intervention and patients donors: fat chance? Transfusion 2011 Jun; 51(6): 1179- with O blood type were slightly older 1187. (62 years old), had a higher prevalen- 6. Munguia-Miranda C, Sánchez-Barrera RG, Tuz K, Alon- ce of hypercholesterolemia and had so-García AL, Cruz M: a higher burden of atherosclerosis Impaired casting glucose detection in blood donor’s popu- with more vascular disease (14). This lation. Rev Med Inst Mex fact is important regarding blood do- Seguro Soc. 2009 Jan-Feb; 47(1): 17-24. nations. A study must be performing 7. Vassallo RR, Stearns FM: Lipemic plasma: a renaissan- to correlate the blood type/group and ce. Transfusion 2011 Feb; dyslipidemia because it may be a 51(6): 1136-1139. coincidental finding. 8. Stearns FM, Stramer SL, Alvarez AW: Verification of Vi- sual Lipemia Sample Another piece of information regarding Suitability by Quantitative Triglyceride Testing. Transfu- strategies for blood drives is that the sion 2005; 45, Supplement, majority of the small groups were from SP199, p89A. the north and central areas of Puerto Rico. This is important, although, the 9. Gomez M, Ramirez M, Disdier O: Prevalence of the meta- finding of a few donors with isolated bolic syndrome among a high triglyceride levels does not have determined Puerto Rican population. PR Health Sci J. any implications for planning blood 2006 Jun; 25(2): 111-116. drives. 10. Cox RA: The hyperlipidemias. Bol Asoc Med PR. 2003 Sep-Oct; 95(5): 36-44. CONCLUSIONS 11. Hørby J, Gyrtrup HJ, Grande P, Vestergaard A: Relation of serum lipoproteins and This data provided important lipids to the ABO blood groups in patients with intermit- knowledge about lipemic plasma and tent claudication. demographics of our blood donor’s J Cardiovasc Surg (Torino) 1989 Jul-Aug; 30(4):533- population. It was confirmed that the 537. main blood type and group O, Rh (+) 12. Carpeggiani C, Coceani M, Landi P, Michelassi C, is related with dyslipidemia as well as L’abbate A: ABO blood group A, Rh (+) by our small sample and alleles: A risk factor for coronary artery disease. An an- they are mostly located in the north giographic study. central municipalities of Puerto Rico. Atherosclerosis 2010 Aug; 211(2): 461-466. What is most interesting is Figure 1 13. Cronenwett JL, Davis JT Jr, Garret HE: ABO blood group per 130,000 of severe hypertriglyce- and serum lipids in female ridemia in which Ralph R. Vassallo atherosclerosis. J Cardiovasc Surg (Torino) 1983 Nov- and Frank M. Stearns (7) reported for Dec; 24(6): 658-661. the Philadelphia NTL were our donors 14. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate 17
  • 4. RJ, Kutcher MA, Sane RESUMEN DC: ABO blood types: Influence on infarct size, procedural characteristics and Se ha identificado un asunto en cuanto a donantes de sangre prognosis. Thromb Res 2008; 123(2): 200-205. puertorriqueños con hipertrigliceridemia presentándose como plasma turbio en hombres con sobre peso y una edad prome- dio 44.5 años. Las donaciones de sangre resultantes en suero ACKNOWLEDEDGMENTS lechoso usualmente son descartadas. Se descartan porque no se pueden realizar las pruebas a las donaciones. Este es The authors thank Dr. Anne F. Eder, Dr. Ralph R. Vassallo, and el primer reporte donde nosotros correlacionamos la turbiedad Dr. Frank M. Stearns from the American Red Cross for their y los factores de riesgo cardiovasculares en la población de editing support and comments. Puerto Rico asi como los tipos y grupos sanguíneos O y A, Rh (+) con dislipidemia. Los donantes de sangre deben recibir un cernimiento mas detallado sobre los riesgos de padecer enfermedad cardiovascular o síndrome metabólico para evitar problemas con su reclutamiento. Every week, ... in your email address... Visit our website: www.asocmedpr.org and click on “Sign up Today” button, fill the form, and receive in your e-mail, each week, news and informa- tion about conferences, continued medical education, and all you need to be well informed about health. Information: www.asocmedpr.org 18